Amcor (AMCR) CFO granted 253,631 stock options at $8.28

Amcor plc (AMCR) reported an insider equity award for its Executive VP, Finance & CFO on a Form 4.

Rhea-AI Filing Summary

Amcor plc (AMCR) reported an insider equity award for its Executive VP, Finance & CFO on a Form 4. As of the reported transactions, the officer beneficially owned 629,748 ordinary shares, including 97,365 shares held as CDIs, all listed as directly owned.

The filing also discloses a grant of employee stock options for 253,631 derivative securities on 09/15/2025 at an exercise price of $8.28 per option. These options are exercisable starting 09/15/2028 and expire on 09/15/2035, and are linked to 253,631 underlying ordinary shares. Following this grant, the officer directly holds 253,631 derivative securities in the form of stock options, which reflects a prorated amount referenced in an earlier 8-K.

Insider Trade Summary

Grant/Award: 253,631 shares

Grant/Award 2 txns

Insider Casamento Michael

Role EXECUTIVE VP, FINANCE & CFO

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Options	253,631	$0.00	$0.00
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Employee Stock Options — 253,631 contracts (Direct); Ordinary Shares — 629,748 shares (Direct)

Footnotes (2)

1. F1. 97,365 of the 629,748 shares are held as CDIs.
2. F2. The Options reported on this Form 4 reflect the prorated amount pursuant to the 8-K filed on October 9, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Amcor plc (AMCR) disclose in this Form 4?

The filing shows an equity award to Amcor plc's Executive VP, Finance & CFO, consisting of employee stock options for 253,631 derivative securities tied to ordinary shares.

How many Amcor (AMCR) shares does the reporting officer beneficially own?

The officer beneficially owns 629,748 ordinary shares, with 97,365 of those shares held as CDIs, all reported as directly owned.

What are the key terms of the Amcor (AMCR) stock options granted to the CFO?

The CFO received 253,631 employee stock options on 09/15/2025 with an exercise price of $8.28 per option, exercisable from 09/15/2028 and expiring on 09/15/2035.

How many derivative securities does the Amcor (AMCR) officer hold after the reported transaction?

Following the reported grant, the officer holds 253,631 derivative securities in the form of employee stock options, all reported as directly owned.

Does this Amcor (AMCR) Form 4 involve a 10b5-1 trading plan?

The form includes a checkbox for transactions pursuant to a Rule 10b5-1(c) trading plan, but the provided content does not indicate that this box was selected.

What is noted in the explanation of responses in this Amcor (AMCR) Form 4?

The explanation states that 97,365 of the 629,748 shares are held as CDIs and that the 253,631 options reflect a prorated amount referenced in an 8-K filed on October 9, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/19/2025 - 04:07 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Casamento Michael

(Last) (First) (Middle)

83 TOWER ROAD NORTH

(Street)

WARMLEY, BRISTOL X0 BS30 8XP

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Amcor plc [ AMCR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EXECUTIVE VP, FINANCE & CFO

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares								629,748(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Options	$8.28	09/15/2025		A		253,631(2)		09/15/2028	09/15/2035	Ordinary Shares	253,631	$0	253,631	D

Explanation of Responses:

1. 97,365 of the 629,748 shares are held as CDIs.

2. The Options reported on this Form 4 reflect the prorated amount pursuant to the 8-K filed on October 9, 2025.

	/s/ Damien Clayton, Attorney-in-Fact	11/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.